IFIH1 and interstitial lung disease: Xu et al. developed an algorithm based on radiomic features to predict 6-month all-cause mortality in baseline HRCT scans of patients affected by anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated interstitial lung disease (MDA5+ DM-ILD); the algorithm was developed on a training set of 121 patients and on a testing set of 31 patients, with an internal validation cohort of 44 patients and an external validation cohort of 32 patients [36].